Results 161 to 170 of about 1,255,526 (344)

Agreement between admission and discharge diagnoses: Analysis by the groups of international classification of diseases, 10th revision

, 2016
Nataša Mihailović, Goran Trajković, Ivana Simić Vukomanović, Svetlana Ristić, Sanja Kocić   +4 more
openalex   +2 more sources

Neuroinflammation in GAD65 Antibody‐Associated Epilepsy Measured Using [18F]DPA‐714 PET/MRI

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The timing for initiating immunotherapy in patients with glutamic acid decarboxylase 65 (GAD65) antibody‐associated epilepsy is a challenge. We used the translocator protein radioligand [18F]DPA‐714 and PET to evaluate brain microglial activation.
Jingjing Chen, Yuying Zhang, Heyu Zhang, Jinming Zhang, Ningning Wang, Xintong Guo, Yicong Liu, Yue Liu, Xiangsong Zhang, Ziyi Chen, Guanzhong Ni   +10 more
wiley   +1 more source

Trends in Dermatopolymyositis Mortality, 1999–2022: A Nationwide Population‐Based Study, United States

Arthritis Care &Research, EarlyView.
We report the national burden of dermatopolymyositis mortality over the past quarter century using the US national vital statistics data. Age‐standardized mortality rates for dermatopolymyositis decreased at an annual rate of 3.8% each year, which was higher than the annual percent decrease for deaths from all other causes.
Elizabeth Matz, Ram R. Singh
wiley   +1 more source

Risk of Stroke After the International Classification of Diseases -Ninth Revision Discharge Code Diagnosis of Hypertensive Encephalopathy

, 2016
Michael P. Lerario, Alexander E. Merkler, Gino Gialdini, Neal S. Parikh, Babak B. Navi, Hooman Kamel   +5 more
openalex   +1 more source

Outcome measures and classification criteria for the rheumatic diseases. A compilation of data from OMERACT (Outcome Measures for Arthritis Clinical Trials), ILAR (International League of Associations for Rheumatology), regional leagues and other groups [PDF]

, 2001
Peter Brooks
openalex   +1 more source

Artificial intelligence for prediction of International Classification of Disease codes

, 2023
Kaitlyn Wallace, Jakir Hossain Bhuiyan Masud   +1 more
openalex   +2 more sources

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

Arthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang, Sandra Blitz, Nick Bansback, Michael Law, Mark Harrison   +4 more
wiley   +1 more source

Coding rules for uncertain and “ruled out” diagnoses in ICD-10 and ICD-11

BMC Medical Informatics and Decision Making
The International Classification of Diseases, 11th Revision (ICD-11) has significantly improved the ability to navigate coding challenges beyond prior iterations of the ICD.
Oluseun O. Atolagbe, Patrick S. Romano, Danielle A. Southern, Wachira Wongtanasarasin, William A. Ghali   +4 more
doaj   +1 more source

Core considerations in the development of the world health organization's international classification of diseases, 11^th Revision

, 2018
GeoffreyM Reed, T. J. Rebello, Shekhar Saxena   +2 more
openalex   +1 more source

Validation of the brief international classification of functioning, disability, and health core set for obstructive pulmonary disease in the Chinese context [PDF]

, 2019
Jingwen Huang, Jan D. Reinhardt, Ranran Dai, Pu Wang, Min Zhou   +4 more
openalex   +1 more source